Conference item
Insulin therapy in type II diabetes.
- Abstract:
-
When diet therapy is no longer effective in keeping the fasting plasma glucose level < 6 mmol l-1, a basal insulin supplement from a long-acting insulin such as ultralente can be added instead of using a sulphonylurea or metformin. The dose of insulin required can be predicted from the level of the fasting plasma glucose and the degree of obesity, which provides an index of the accompanying insulin resistance. The risk of hypoglycaemia is minimal provided that the dose is adjusted accordin...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Diabetes research and clinical practice
- Volume:
- 28 Suppl
- Pages:
- S179-S184
- Publication date:
- 1995-08-01
- Event title:
- Hoechst Satellite Symposium on New Oral Antidiabetic Agents - From Today to Tomorrow, at the 15th International-Diabetes-Federation Congress
- DOI:
- EISSN:
-
1872-8227
- ISSN:
-
0168-8227
- Source identifiers:
-
22150
Item Description
- Keywords:
- Pubs id:
-
pubs:22150
- UUID:
-
uuid:6256fea9-713b-44b8-9baf-e6ea1647252a
- Local pid:
- pubs:22150
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 1995
If you are the owner of this record, you can report an update to it here: Report update to this record